top of page

🎺 Press Release: CLEVERNAS_3 🎺

6 Jul 2026

New IOF investment advances commercially attractive, non-antibiotic technology towards proof of efficacy

Ghent, Belgium – 3 July 2026 – Ghent University has awarded a new Industrial Research Fund (IOF) grant of 248kEURO to accelerate the development of a novel intramammary probiotic technology designed to improve udder health in dairy cows while reducing the need for preventive antibiotic use. The newly funded project, CLEVERNAS_3, represents the next milestone in the development of a first-in-class, non-antibiotic solution for dry cow therapy and further strengthens its commercial potential.


👇 read the full text here

bottom of page